Severity-weighted economically justifiable price under NICE QALY weights

NICE's committee may apply a greater weight to QALYs for conditions with a high degree of severity, 1.2 or 1.7 depending on the absolute and proportional QALY shortfall (PMG36 sections 6.2.16 to 6.2.18). Multiplying Delta_E by the weight w in HE-FM-EJP-001 raises the EJP by w minus 1, times lambda times Delta_E, divided by U. With w equal to 1 the formula returns the unweighted EJP.

Signature

EJP_w = (w * lambda * Delta_E - Delta_C_other) / U
Inputs
InputsDefinitionUnit
wQALY weight for severity: 1 where no severity modifier applies, otherwise 1.2 or 1.7 under PMG36 table 6.1multiplier, no unit
lambdaCost-effectiveness threshold before any severity weightmoney per QALY
Delta_EExpected discounted QALYs per patient with the medicine minus those with the comparator, before weighting, above zeroQALYs per patient
Delta_C_otherExpected discounted incremental cost per patient excluding the medicine's acquisition cost, net of savingsmoney per patient
UDiscounted number of units of the medicine per patient, above zerounits per patient
Output
EJP_wEconomically justifiable price per unit when the QALY gain carries the severity weight wmoney per unit

Function

Economically justifiable price function solving the ICER for the unit price

Maps a cost-effectiveness threshold, the incremental QALYs per patient, the incremental cost per patient other than the new medicine's acquisition cost and the discounted number of units per patient to the highest price per unit at which the incremental cost-effectiveness ratio equals the threshold. It solves the two-option ICER of HE-FM-ICER-001 with the medicine's price as the unknown, and the same price sets the incremental net monetary benefit of HE-FM-NMB-002 to zero. The algebra matches the break-even price HE-FM-BEA-001 and, per patient, the payer's maximum price HE-FM-BARG-002; this package adds the threshold range, the NICE severity weight and the probabilistic forms used in an EJP analysis. Notation follows the Economically Justifiable Price article.

Try this function

Implementations

  • Excel

    Severity-weighted EJP from named cells

    With the weight in a cell named SeverityWeight and the other inputs in Threshold, DeltaE, DeltaCOther and Units, Excel returns the severity-weighted EJP per unit.

    =(SeverityWeight*Threshold*DeltaE-DeltaCOther)/Units

Assumptions

  • Severity weight multiplies the QALY gain only

    The weight applies to the incremental QALYs, not to the costs. It is set from the QALY shortfall of the population for which the medicine will be used, with discounting at the reference-case rate, and the shortfall measure that implies the greater severity sets the weight (PMG36 sections 6.2.16 to 6.2.18).

Worked examples

  • Drug X EJP with a severity weight of 1.2

    With a severity weight of 1.2 Drug X's EJP at GBP 25,000 per QALY rises from GBP 740 to GBP 900 per pack, as in the article.

    w = 1.2; lambda = 25000; Delta_E = 0.80; Delta_C_other = 1500; U = 25; EJP_w = 900
  • Drug X EJP with a severity weight of 1.7

    With the higher weight of 1.7 the EJP would be GBP 1,300 per pack (computed here for illustration).

    w = 1.7; lambda = 25000; Delta_E = 0.80; Delta_C_other = 1500; U = 25; EJP_w = 1300
  • Drug X EJP with no severity weight

    A weight of 1 returns the unweighted EJP of GBP 740 per pack, a limiting case that checks the implementation.

    w = 1; lambda = 25000; Delta_E = 0.80; Delta_C_other = 1500; U = 25; EJP_w = 740

Common errors

  • Applying the severity weight to the unweighted EJP

    Multiplying Drug X's unweighted EJP of GBP 740 by 1.2 gives GBP 888 per pack instead of GBP 900, because it also scales Delta_C_other, which the weight does not touch (computed here for illustration). The weight belongs on the QALY gain.

Sources

  • NICE QALY weights for severity

    National Institute for Health and Care Excellence. NICE technology appraisal and highly specialised technologies guidance: the manual (PMG36). London: NICE; published 31 January 2022, last updated 31 March 2026. Sections 6.2.16 to 6.2.18 and table 6.1: the committee may apply a greater weight to QALYs for conditions with a high degree of severity; weights of 1.2 and 1.7 are set by absolute and proportional QALY shortfall, whichever implies the greater severity.

    View source →

Canonical Identity

Severity-weighted economically justifiable price under NICE QALY weights | HealthEconomics.wiki